Warsaw breakage syndrome is a rare genetic condition. Fewer than 10 cases have been reported by 2018.   Its clinical manifestations affect several organ systems.  This condition is caused by mutations in the DDX11 gene which is located on the short arm of chromosome 12 (12p11).  This gene encodes a iron-sulfur containing DNA helicase that belongs to the superfamily 2 of helicases. This protein interacts with the 9-1-1 checkpoint complex protein.  The inheretnce pattern is not yet clear.  These include The diagnosis may be suspected on clinical grounds and can be confirmed by sequencing the DDX1 gene.  There is no known curative treatment for this condition presently. Management is supportive.  This condition was first described in 2010.  